Xoma Corp Reports Results For The Quarter Ended In March: Earnings Summary

Xoma Royalty

09/05/2024 19:31

* XOMA Corp  XOMA.OQ  reported a quarterly adjusted loss
of 86
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -62
cents.  The mean expectation of three analysts for the quarter
was for a loss of 81 cents per share. Wall Street expected
results to range from -85 cents to -76 cents per share.
    * Revenue rose 241% to $1.49 million from a year ago;
analysts
expected $1.33 million. 
    * The company reported a quarterly loss of $9.96 million.
    * XOMA Corp shares had risen by 0.6% this quarter and
gained 30.8%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 40.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for XOMA Corp is
$57.00 
This summary was machine generated from LSEG data May 9 at 06:30
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.81          -0.86          Missed
 Dec. 31 2023      -0.36          -0.49          Missed
 Sep. 30 2023      -0.48          -0.60          Missed
 Jun. 30 2023      -0.52          -0.45          Beat